ZNF133 is associated with infliximab responsiveness in patients with inflammatory bowel diseases.
Jung ES, Choi KW, Kim SW, Hübenthal M, Mucha S, Park J, Park Z, Ellinghaus D, Schreiber S, Franke A, Oh WY, Cheon JH.
Jung ES, et al. Among authors: cheon jh.
J Gastroenterol Hepatol. 2019 Oct;34(10):1727-1735. doi: 10.1111/jgh.14652. Epub 2019 Apr 1.
J Gastroenterol Hepatol. 2019.
PMID: 30851117